Skip to main content
SpringerLink
Log in

Probiotics in Clinical Practice as Therapeutics Against Enteric Disorders

  • Chapter
  • First Online:
Probiotic Bacteria and Enteric Infections

Abstract

Probiotics are useful in mild enteric disorders that are limited to the presence of individual symptoms such as diarrhoea, constipation, and bloating. More controversial is their use in colonic diverticular disease or in one of the most common disorders, namely the irritable bowel syndrome. With few exceptions and in a limited well defined patients’ group, no evidence exists that probiotics induce and maintain remission in patients with inflammatory bowel disease. In this chapter we review the current evidence of the value of probiotics in clinical practice of the following enteric disorders as well as the formulations and compositions of specific probiotics. It will be clear that most of the compositions used are not classified as medicaments, and most of them are free to obtain as “over-the-counter” preparations administered without medical prescriptions. Therefore, their use as therapeutics is very limited at present. This situation is likely to change in coming years. As shown in other chapters of this book a multidisciplinary approach is bringing scientific protocols to the field of probiotics and new technology to study the complicated field of gut microbiology and ecology is being applied to the study of functional and inflammatory diseases of the gut.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Barbara G, Cremon C, Pallotti F, De Giorgio R, Stanghellini V, Corinaldesi R (2009) Postinfectious irritable bowel syndrome. J Pediatr Gastroenterol Nutr 48(Suppl 2):S95–97 (Apr)

    Article  PubMed  CAS  Google Scholar 

  • Bishop R (1999) Ruth Bishop: rotaviruses and vaccines. Interview by Amanda Tattam. Lancet 353(9167):1860 (May)

    CAS  Google Scholar 

  • Bogardus ST Jr (2006) What do we know about diverticular disease? A brief overview. J Clin Gastroenterol 40(Suppl 3):S108–S111 (Aug)

    Article  PubMed  Google Scholar 

  • Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D (2001) Effects of probiotic administration upon the composition and enzymatic activity of human faecal microbiota in patients with irritable bowel syndrome or functional diarrhoea. Res Microbiol 152(8):735–741 (Oct)

    Article  PubMed  CAS  Google Scholar 

  • Byrne CM, Clyne M, Bourke B (2007) Campylobacter jejuni adhere to and invade chicken intestinal epithelial cells in vitro. Microbiology 153(Pt 2):561–569 (Feb)

    Article  PubMed  CAS  Google Scholar 

  • Campieri M, Gionchetti P (1999) Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? Gastroenterology 116(5):1246–1249 (May)

    Article  PubMed  CAS  Google Scholar 

  • Campieri M, Rizzello F, Venturi A, Poggioli G, Ugolini F, Helwig U et al (2000) Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of crohn’s disease: a randomized controlled study vs Mesalamine. Gastroenterology 118(4179):A781

    Article  Google Scholar 

  • Comparato G, Pilotto A, Franze A, Franceschi M, Di Mario F (2007) Diverticular disease in the elderly. Dig Dis 25(2):151–159

    Article  PubMed  Google Scholar 

  • Cremonini F, Di Caro S, Nista EC, Bartolozzi F, Capelli G, Gasbarrini G et al (2002) Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 16(8):1461–1467 (Aug)

    Article  PubMed  CAS  Google Scholar 

  • Crushell E, Harty S, Sharif F, Bourke B (2004) Enteric campylobacter: purging its secrets? Pediatr Res 55(1):3–12 (Jan)

    Article  PubMed  Google Scholar 

  • Cuomo R, Savarese MF, Gargano R (2007) Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues. Dig Dis 25(3):241–244

    Article  PubMed  Google Scholar 

  • Dendukuri N, Costa V, McGregor M, Brophy JM (2005) Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhoea: a systematic review. Can Med Assoc J 173(2):167–170 (19 July)

    Article  Google Scholar 

  • De Paula JA, Carmuega E, Weill R (2008) Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation. Acta Gastroenterol Latinoam 38(1):16–25 (Mar)

    PubMed  Google Scholar 

  • Duffy LC, Zielezny MA, Riepenhoff-Talty M, Dryja D, Sayahtaheri-Altaie S, Griffiths E et al (1994) Effectiveness of Bifidobacterium bifidum in mediating the clinical course of murine rotavirus diarrhoea. Pediatr Res 35(6):690–695 (June)

    Article  PubMed  CAS  Google Scholar 

  • Fric P, Zavoral M (2003) The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 15(3):313–315 (Mar)

    Article  PubMed  Google Scholar 

  • Garcia Rodriguez LA, Ruigomez A, Panes J (2006) Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 130(6):1588–1594 (May)

    Article  Google Scholar 

  • Gawronska A, Dziechciarz P, Horvath A, Szajewska H (2007) A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther 25(2):177–184 (15 Jan)

    Article  PubMed  CAS  Google Scholar 

  • Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125(6):1401–1412 (June)

    PubMed  CAS  Google Scholar 

  • Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G et al (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119(2):305–309 (Aug)

    Article  PubMed  CAS  Google Scholar 

  • Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P et al (2003) Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124(5):1202–1209 (May)

    Article  PubMed  Google Scholar 

  • Gorbach SL, Chang TW, Goldin B (1987) Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 2(8574):1519 (26 Dec)

    Article  PubMed  CAS  Google Scholar 

  • Guandalini S (2002) Use of Lactobacillus-GG in paediatric Crohn’s disease. Dig Liver Dis 34(Suppl 2):S63–S65 (Sept)

    Article  PubMed  Google Scholar 

  • Guslandi M, Giollo P, Testoni PA (2003) A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 15(6):697–698 (June)

    Article  PubMed  Google Scholar 

  • Hjern F, Johansson C, Mellgren A, Baxter NN, Hjern A (2006) Diverticular disease and migration—the influence of acculturation to a Western lifestyle on diverticular disease. Aliment Pharmacol Ther 23(6):797–805 (15 Mar)

    Article  PubMed  CAS  Google Scholar 

  • Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P (2009) A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 9:15

    Article  PubMed  Google Scholar 

  • Isolauri E, Kaila M, Mykkanen H, Ling WH, Salminen S (1994) Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci 39(12):2595–2600 (Dec)

    Article  PubMed  CAS  Google Scholar 

  • Jun S, Stollman N (2002) Epidemiology of diverticular disease. Best Pract Res Clin Gastroenterol 16(4):529–542 (Aug)

    Article  PubMed  Google Scholar 

  • Kalischuk LD, Inglis GD, Buret AG (2007) Strain-dependent induction of epithelial cell oncosis by Campylobacter jejuni is correlated with invasion ability and is independent of cytolethal distending toxin. Microbiology 153(Pt 9):2952–2963 (Sept)

    Article  PubMed  CAS  Google Scholar 

  • Katz JA (2003) Prevention is the best defense: probiotic prophylaxis of pouchitis. Gastroenterology 124(5):1535–1538 (May)

    Article  PubMed  Google Scholar 

  • Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM et al (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17(7):895–904 (1 Apr)

    Article  PubMed  CAS  Google Scholar 

  • King TS, Elia M, Hunter JO (1998) Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352(9135):1187–1189 (10 Oct)

    Article  PubMed  CAS  Google Scholar 

  • Karimi O, Pena AS (2003) Probiotics: isolated bacteria strain or mixtures of different strains? Two different approaches in the use of probiotics as therapeutics. Drugs Today 39(8):565–597 (Aug)

    Article  PubMed  CAS  Google Scholar 

  • Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ (2003) Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 17(11):655–659 (Nov)

    PubMed  Google Scholar 

  • Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M et al (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53(11):1617–1623 (Nov)

    Article  PubMed  CAS  Google Scholar 

  • Kuisma J, Mentula S, Jarvinen H, Kahri A, Saxelin M, Farkkila M (2003) Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 17(4):509–515 (15 Feb)

    Article  PubMed  CAS  Google Scholar 

  • Ludeman L, Warren BF, Shepherd NA (2002) The pathology of diverticular disease. Best Pract Res Clin Gastroenterol 16(4):543–562 (Aug)

    Article  PubMed  Google Scholar 

  • Madden JA, Hunter JO (2002) A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr 88 (Suppl 1):S67–S72 (Sept)

    Article  PubMed  CAS  Google Scholar 

  • Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM (2006) Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 131(2):445–450, quiz 660 (Aug)

    Article  PubMed  Google Scholar 

  • Marteau P, Lemann M, Seksik P, Laharie D, Colombel JF, Bouhnik Y et al (2006) Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial. Gut 55(6):842–847 (June)

    Article  PubMed  CAS  Google Scholar 

  • McFarland LV (2006) Meta-analysis of probiotics for the prevention of antibiotic associated diarrhoea and the treatment of Clostridium difficile disease. Am J Gastroenterol 101(4):812–822 (Apr)

    Article  PubMed  Google Scholar 

  • McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA et al (1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. J Am Med Assoc 271(24):1913–1918 (June)

    Article  CAS  Google Scholar 

  • McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Moyer KA, Melcher SA et al (1995) Prevention of beta-lactam-associated diarrhoea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 90(3):439–448 (Mar)

    PubMed  CAS  Google Scholar 

  • Mearin F, Perez-Oliveras M, Perello A, Vinyet J, Ibanez A, Coderch J et al (2005) Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 129(1):98–104 (June)

    Article  PubMed  Google Scholar 

  • Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC et al (2004) Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53(1):108–114 (Jan)

    Article  PubMed  CAS  Google Scholar 

  • Niedzielin K, Kordecki H, Birkenfeld B (2001) A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299 V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13(10):1143–1147 (Oct)

    Article  PubMed  CAS  Google Scholar 

  • Ouwehand AC, Lagstrom H, Suomalainen T, Salminen S (2002) Effect of probiotics on constipation, faecal azoreductase activity and faecal mucin content in the elderly. Ann Nutr Metab 46(3–4):159–162.

    Article  PubMed  CAS  Google Scholar 

  • Pare P, Ferrazzi S, Thompson WG, Irvine EJ, Rance L (2001) An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 96(11):3130–3137 (Nov)

    Article  PubMed  CAS  Google Scholar 

  • Patterson JA, Burkholder KM (2003) Application of prebiotics and probiotics in poultry production. Poult Sci 82(4):627–631 (Apr)

    PubMed  CAS  Google Scholar 

  • Peppercorn MA (2004) The overlap of inflammatory bowel disease and diverticular disease. J Clin Gastroenterol 38(5, Suppl 1):S8–S10 (May–June)

    Article  PubMed  Google Scholar 

  • Pillai A, Nelson R (2008) Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev 2008(1):CD004611

    Google Scholar 

  • Posserud I, Stotzer PO, Bjornsson ES, Abrahamsson H, Simren M (2007) Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 56(6):802–808 (June)

    Article  PubMed  Google Scholar 

  • Prantera C, Scribano ML (2002) Probiotics and Crohn’s disease. Dig Liver Dis 34(Suppl 2):S66–S67 (Sept)

    Article  PubMed  Google Scholar 

  • Qiao H, Duffy LC, Griffiths E, Dryja D, Leavens A, Rossman J et al (2002) Immune responses in rhesus rotavirus-challenged BALB/c mice treated with bifidobacteria and prebiotic supplements. Pediatr Res 51(6):750–755 (June)

    Article  PubMed  Google Scholar 

  • Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA (1995) Lactobacillus GG promotes recovery from acute nonbloody diarrhoea in Pakistan. Pediatr Infect Dis J 14(2):107–111 (Feb)

    Article  PubMed  CAS  Google Scholar 

  • Simmering R, Blaut M (2001) Pro- and prebiotics—the tasty guardian angels? Appl Microbiol Biotechnol 55(1):19–28 (Jan)

    Article  PubMed  CAS  Google Scholar 

  • Sonnenberg A, Koch TR (1989) Physician visits in the United States for constipation: 1958 to 1986. Dig Dis Sci 34(4):606–611 (Apr)

    Article  PubMed  CAS  Google Scholar 

  • Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M et al (2000) Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47(6):804–811 (Dec)

    Article  PubMed  CAS  Google Scholar 

  • Stermer E, Lubezky A, Potasman I, Paster E, Lavy A (2006) Is traveler’s diarrhoea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis 43(7):898–901 (Oct)

    Article  PubMed  Google Scholar 

  • Stewart WF, Liberman JN, Sandler RS, Woods MS, Stemhagen A, Chee E et al (1999) Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 94(12):3530–3540 (Dec)

    Article  PubMed  CAS  Google Scholar 

  • Szajewska H, Skorka A, Dylag M (2007a) Meta-analysis: saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 25(3):257–264 (Feb)

    Article  CAS  Google Scholar 

  • Szajewska H, Skorka A, Ruszczyński M, Gieruszczak-Bialek D (2007b) Meta-analysis: lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther 25(8):871–881 (Apr)

    Article  CAS  Google Scholar 

  • Ternhag A, Torner A, Svensson A, Ekdahl K, Giesecke J (2008) Short- and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis 14(1):143–148 (Jan)

    Article  PubMed  Google Scholar 

  • Tursi A, Brandimarte G, Giorgetti GM, Elisei W (2006) Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study. J Clin Gastroenterol 40(4):312–316 (Apr)

    Article  PubMed  Google Scholar 

  • Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ (1999) Lactobacillus GG in the prevention of antibiotic-associated diarrhoea in children. J Pediatr 135(5):564–568 (Nov)

    Article  PubMed  CAS  Google Scholar 

  • Van Gossum A, Dewit O, Louis E, de Hertogh G, Baert F, Fontaine F et al (2007) Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn’s disease after lleo-caecal resection. Inflamm Bowel Dis 13(2):135–142 (Feb)

    Article  PubMed  Google Scholar 

  • Van Niel CW, Feudtner C, Garrison MM, Christakis DA (2002) Lactobacillus therapy for acute infectious diarrhoea in children: a meta-analysis. Pediatrics 109(4):678–684 (Apr)

    Article  PubMed  Google Scholar 

  • Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E, Brigidi P et al (1999) Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 13(8):1103–1108 (Aug)

    Article  PubMed  CAS  Google Scholar 

  • Wine E, Chan VL, Sherman PM (2008) Campylobacter jejuni mediated disruption of polarized epithelial monolayers is cell-type specific, time dependent, and correlates with bacterial invasion. Pediatr Res 64(6):599–604 (Dec)

    Article  PubMed  Google Scholar 

  • Wine E, Gareau MG, Johnson-Henry K, Sherman PM (2009) Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells. FEMS Microbiol Lett 300(1):146–152 (Nov)

    Article  PubMed  CAS  Google Scholar 

  • Wunderlich PF, Braun L, Fumagalli I, D’Apuzzo V, Heim F, Karly M et al (1989) Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 17(4):333–338 (July–Aug)

    PubMed  CAS  Google Scholar 

  • Young KT, Davis LM, Dirita VJ (2007) Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 5(9):665–679 (Sept)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, VU University Medical Center, Laboratory of Immunogenetics, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands

    Ouafae Karimi & A. S. Peña

Authors
  1. Ouafae Karimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. S. Peña
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. S. Peña .

Editor information

Editors and Affiliations

  1. Faculty of Veterinary Medicine, Department of Veterinary Pathology, Sokoine University of Agriculture, Chuo Kikuu, Morogoro, Tanzania

    J.J. Malago

  2. Division Pathology, Dept of Pathobiology, Utrecht University, Yalelaan 1, Utrecht, 3508 TD, Netherlands

    J.F.J.G. Koninkx

  3. Biotechnical Faculty, Zootechnical Department, University of Ljubljana, Domžale, 1230, Slovenia

    R. Marinsek-Logar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Karimi, O., Peña, A.S. (2011). Probiotics in Clinical Practice as Therapeutics Against Enteric Disorders. In: Malago, J., Koninkx, J., Marinsek-Logar, R. (eds) Probiotic Bacteria and Enteric Infections. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0386-5_15

Download citation

Publish with us

Policies and ethics

Search

Navigation